371 related articles for article (PubMed ID: 33486566)
1. P2X7 receptor: a critical regulator and potential target for breast cancer.
Zhu X; Li Q; Song W; Peng X; Zhao R
J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
[TBL] [Abstract][Full Text] [Related]
2. Uncaria tomentosa extract alters the catabolism of adenine nucleotides and expression of ecto-5'-nucleotidase/CD73 and P2X7 and A1 receptors in the MDA-MB-231 cell line.
Santos KF; Gutierres JM; Pillat MM; Rissi VB; Santos Araújo MD; Bertol G; Gonçalves PB; Schetinger MR; Morsch VM
J Ethnopharmacol; 2016 Dec; 194():108-116. PubMed ID: 27590731
[TBL] [Abstract][Full Text] [Related]
3. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
7. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production.
Park M; Kim J; Phuong NTT; Park JG; Park JH; Kim YC; Baek MC; Lim SC; Kang KW
Sci Rep; 2019 Aug; 9(1):11587. PubMed ID: 31406126
[TBL] [Abstract][Full Text] [Related]
9. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
10. Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives.
Roger S; Jelassi B; Couillin I; Pelegrin P; Besson P; Jiang LH
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2584-602. PubMed ID: 25450340
[TBL] [Abstract][Full Text] [Related]
11. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
12. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib.
Salahuddin MM; Omran GA; Helmy MW; Houssen ME
Curr Issues Mol Biol; 2021 Dec; 43(3):2199-2209. PubMed ID: 34940128
[TBL] [Abstract][Full Text] [Related]
13. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
15. ATP-gated P2X7 receptor as a potential target for prostate cancer.
Qiao C; Tang Y; Li Q; Zhu X; Peng X; Zhao R
Hum Cell; 2022 Sep; 35(5):1346-1354. PubMed ID: 35657562
[TBL] [Abstract][Full Text] [Related]
16. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics.
Wei L; Syed Mortadza SA; Yan J; Zhang L; Wang L; Yin Y; Li C; Chalon S; Emond P; Belzung C; Li D; Lu C; Roger S; Jiang LH
Neurosci Biobehav Rev; 2018 Apr; 87():192-205. PubMed ID: 29453990
[TBL] [Abstract][Full Text] [Related]
17. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.
Bartlett R; Stokes L; Sluyter R
Pharmacol Rev; 2014 Jul; 66(3):638-75. PubMed ID: 24928329
[TBL] [Abstract][Full Text] [Related]
18. Mechanical stress-induced interleukin-1beta expression through adenosine triphosphate/P2X7 receptor activation in human periodontal ligament cells.
Kanjanamekanant K; Luckprom P; Pavasant P
J Periodontal Res; 2013 Apr; 48(2):169-76. PubMed ID: 22881405
[TBL] [Abstract][Full Text] [Related]
19. ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer.
Zuo C; Xu YS; He PF; Zhang WJ
Eur J Med Chem; 2023 Dec; 261():115877. PubMed ID: 37857146
[TBL] [Abstract][Full Text] [Related]
20. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
